Knight Therapeutics (KHTRF) Q2 2026 Earnings

7MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.1
-0.03
0.03
0.09

Details

Expected EPS
0.01917143964
Actual EPS
0.0934596
Surprise EPS
0.07
Surprise Percent
+387.49%

Description

Knight Therapeutics (KHTRF) has reported earnings of 0.0934596 per share for Q2 2026.

0 Comments

Share your thoughts